CSI Market
Sign In | Register

Gyre Therapeutics Inc (GYRE) Annual Balance Sheets

Annual · GAAP · USD millions
Access GYRE quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Gyre Therapeutics Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent37.07
Short-term Investments, Total15.36
Cash & Short-term Investments52.00
Accounts receivable31.08
Other Receivables, Net, Current0.23
Notes, Loans and Financing Receivable, Net, Current AC5.64
Inventories10.17
Other Current Assets2.83
Prepaid Expense And Other Assets Current0.00
Total Current Assets102.37
Equipment/Property/Plant Net23.60
Intangible Assets4.73
Accounts, Notes, Loans and Financing Receivable, Net, Noncurrent, Total0.00
Other Assets, Noncurrent35.44
Prepaid Assets Current1.34
Operating Lease Right Of Use Asset1.13
Total Assets166.13
Liabilities
Accounts Payable, Current AC0.12
Accrued Liabilities And Other Liabilities14.35
Other Liabilities, Current0.88
Accrued Income Taxes, Current TA2.94
Deferred Revenue, Current DE0.00
Total Current Liabilities18.29
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE2.96
Deferred Revenue, Noncurrent DE0.85
Other liabilities, Noncurrent1.75
Contract With Customer Liability Current0.01
Operating Lease Liability Noncurrent0.30
C V R Derivative Liability Noncurrent-
Total Liabilities23.85
Stockholders' Equity
Statutory Reserve3.10
Common Stock Value0.09
Additional Paid In Capital Common Stock172.05
Retained Earnings / Accumulated Deficit-68.43
Other Equity-0.78
Common Stockholder's Equity106.03
Non-controlling interests & other36.25
Total Stockholder's Equity142.28
Liabilities & Stockholder's Equity166.13
4 historic quarters locked

Sign in to unlock the full Gyre Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Gyre Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-106251

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License